Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical Prostatectomy for High-Risk Localised or Locally Advanced Prostate Cancer By Ogkologos - June 3, 2026 65 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PROTEUS study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis,... February 10, 2026 Darolutamide in Combination with ADT and Docetaxel Increases Overall Survival in... February 27, 2023 Treatment with Brigatinib Results in Radiographic Responses and Clinical Benefit in... July 4, 2024 FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax... June 3, 2026 Load more HOT NEWS Cancer Survivor And His Organ Donor Run NYC Marathon Together To... Overall Survival Significantly Longer with Darolutamide in Non-metastatic CRPC FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma New on NCI Websites for December 2018
